Fig. 1From: Validation of the Meet-URO score in metastatic clear cell renal cell carcinoma patients receiving second or third-line tyrosine kinase inhibitors-immune checkpoint inhibitors combination therapyKaplan–Meier curves for OS according to the Meet-URO scoreBack to article page